New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2014
07:15 EDTICPTIntercept shares should be bought amid biotech weakness, says Oppenheimer
After meeting with Intercept's management, Oppenheimer believes that the company's management successfully explained issues involving OCA lipids, and the firm is now more confident in the company's ability to deal with future regulatory uncertainties. Oppenheimer keeps an Outperform rating on the stock.
News For ICPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
10:05 EDTICPTSummer Street specialty pharma/biotech analyst analyst/industry conference call
Subscribe for More Information
September 22, 2014
09:15 EDTICPTIntercept recent weakness a buying opportunity, says Summer Street
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use